Immunisation with gp160 in HIV-1 infection.
Fiala
C
C
Stewart
G T
GT
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D018791:CD4 Lymphocyte Count; D005260:Female; D019302:HIV Envelope Protein gp160 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D012107:Research Design; D013601:T-Lymphocytes / Q000276:immunology; D017211:Treatment Failure; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology*
D016915:AIDS Vaccines; D019302:HIV Envelope Protein gp160; D014614:Vaccines, Synthetic